On December 10, 2012, Array BioPharma issued a press release announcing clinical data on two drug candidates, ARRY-520, a KSP inhibitor, and ARRY-614, a dual p38/Tie2 inhibitor, presented at the 2012 Annual Meeting of the American Society of Hematology (ASH) in Atlanta, Georgia.

A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and incorporated herein by reference.

(d) Exhibits

Exhibit No.   Description
   99.1       Press Release announcing clinical data presented at the 2012 ASH
              Annual Meeting on ARRY-520, a KSP inhibitor, and ARRY-614, a dual
              p38/Tie2 inhibitor